Santa Clara, California-based global consulting and research firm Frost & Sullivan has awarded OrthAlign its 2019 North American Technology Leadership Award. Each year, Frost & Sullivan presents the Technology Leadership Award to a company that has demonstrated uniqueness in developing and leveraging new technologies that deliver significant customer value.
OrthAlign Receives Frost & Sullivan’s Technology Leadership Award
2 min read Premium comments
Secondary#orthalign#technologyleadershipaward#frost&sulllivan
OrthAlign is an Aliso Viejo, California-based medical device and technology company that strives to deliver healthier and more pain-free lifestyles to joint replacement patients. OrthAlign has created handheld, sensor-based technology that delivers industry-leading intraoperative surgical guidance and economics.
OrthAlign’s smart technology platform uses micro-electromechanical sensors to register patient anatomy intraoperatively and live-navigate instrumentation.
“OrthAlign has created a new competitive positioning in the orthopedic implant alignment landscape that at once takes on industry-leading computer-assisted surgery systems and conventional mechanical guides,” said Bhargav Rajan, leader, Medical Devices & Imaging Team at Frost & Sullivan. “The economic benefits of a single-use device compares favorably against robotic systems without compromising clinical outcomes.”
OrthAlign’s technology provides surgeons with real-time access to information about the alignment and balance of implants, in the palm of their hands. This technology eliminates the need for pre-operative imaging or for large, image-guided systems inside the OR. OrthAlign technology is currently used in total knee, total hip, and unicompartmental knee arthroplasties.
OrthAlign’s technology comes as a disposable single-use device. It is not reliant on any capital equipment. Hospitals and surgery centers can simultaneously deploy the tech in multiple operating rooms. This “distributed navigation” reflects a significant operational improvement over robotic and navigation systems whose utility is often tied to the need to acquire individual pieces of capital equipment.
OrthAlign Chief Technology Officer Jamy Gannoe told OTW, “We are excited and honored to receive this award. Our extraordinary team is devoted to adding useful features, functionality and new smart technology products to our growing portfolio.”
Gannoe continued, “Building upon the success of KneeAlign and HipAlign, we will continue to deliver a cadence of new innovations that seamlessly, simply and economically bring objectivity to many more surgical techniques and maneuvers performed by orthopedic surgeons around the world. Smart, economical, handheld, seamlessly integrated technology is the next chapter in orthopedic navigation.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.